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ABSTRACT 
Objective: The present study was designed to evaluate the effect of zinc oxide nanoparticles (ZnO NPs) on Aluminum chloride (AlCl3
Methods: Animals were divided into, I-control group; rats received saline, II-AlCl
)-induced hepato-
renal injury.  
3 group; animals received 100 mg AlCl3/kg body weight, III-ZnO NPs group; 
rats received 10 mg ZnO NPs/kg body weight, and IV group ZnO NPs+AlCl3
Results: ZnO NPs treatment to AlCl
. All rats were administered their respective doses daily for 6 w. Hepatorenal 
function parameters in sera; aminotransferases, bilirubin, urea, and creatinine were estimated. Lipid peroxide level and nitrite\nitrate ratio, glutathione 
content, glutathione peroxidase, glutathione reductase, catalase, superoxide dismutase activities and interleukin-1β, tumor necrosis factor-α levels were 
determined in both tissues. The histopathological and the immunohistochemical investigations of nuclear factor-kB expression were carried out.  
3-intoxicated rats significantly reduced Al accumulation (at p<0.05) in the hepatorenal tissue and increased zinc 
accumulation (at p<0.05) in liver and kidney, respectively, with respect to AlCl3-group, thus inhibiting oxidative stress and inflammation parameters 
represented by lipid peroxidation and nitric oxide levels (at p<0.05) compared to AlCl3 group and elevated antioxidant parameters (at p<0.05), 
compared to AlCl3 treated group, while suppressed interleukin-1β, tumor necrosis factor-α levels (at p<0.05) and the nuclear factor-kB activation in liver 
and kidney, especially in the kidney if compared to AlCl3-treated group. Hepatorenal function indices indicated significant decreases compared to AlCl3
Conclusion: Results indicated the ameliorative effect of ZnO NPs on aluminum-induced hepato-renal damage. 
 
group (at p<0.05).  
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INTRODUCTION 
Aluminum (Al) represents about 8% of the total mineral constituents of 
the earth’s crust and classified among the most harmful toxicants in the 
environment [1]. Humans are exposed mainly to Al through drinking 
water, food additives, and packaging, cooking utensils, deodorants and 
medicines [2]. Al accumulates in different organs causing neurological, 
respiratory, immunological, skeletal and hematopoietic problems [3]. 
Reports indicated bile duct hyperplasia, liver fatty degeneration and a 
disturbance in transaminases and alkaline phosphatase activities 
following Al-intoxication [4, 5]. Chronic administration of Al-induced 
changes in the morphological structure of glomeruli and proximal 
tubular cells and affected the levels of kidney function parameters [6]. 
Oxidative stress is an important mechanism involved in Al-induced 
hepato-renal toxicity, through enhanced lipid peroxidation, nitric oxide 
formation and depressed cellular glutathione [5, 7].  
Metal oxide nanoparticles received attention in medicine, for the 
prevention and treatment of diseases characterized by free radicals 
production [8]. Zinc oxide nanoparticles (ZnO NPs) have been used in 
different industrial products including textiles, paints, toothpaste, 
cosmetics, and bio-imaging probes. They were also used in gene-
delivery drugs and as a food additive due to their antibacterial and 
antifungal properties [9-11]. ZnO NPs were used for their antioxidant 
activities [12] but could also induce cytotoxic effects [13].  
As Al is detoxified in the liver and excreted mainly by the kidneys, the 
present study was designed to evaluate the role of ZnO NPs against Al-
induced hepato-renal toxicity in rats, through estimation of Zinc and Al 
accumulation in liver and kidney, measurement of both organs function, 
oxidative stress and inflammatory status and histopathological 
investigation of hepato-renal tissue and immunohistochemical examination 
of nuclear factor-kappa B (NF-κB) protein expression in both tissues. 
MATERIALS AND METHODS 
Chemicals 
Aluminum chloride (AlCl3
Animals and experimental design 
) anhydrous (CAS number, 7446-70-0) and 
zinc oxide nanoparticles (ZnO NPs), ˂ 100 nm particle size (TEM), ≤40 
nm average particle size (CAS number, 1314-13-2) were obtained and 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Chemicals and 
reagents used throughout the experiment were of analytical grade. 
Male Wistar rats of ten w old (200–220 g) were obtained from the 
Holding Company for Biological Products and Vaccines (VACSERA) 
Cairo, Egypt. Animals were housed in wire polypropylene cages in a 
room under standard laboratory conditions (12h light-dark cycle; 
25±2 °C) and were provided with water and animal standard diet ad 
libitum, as described [14], and allowed to acclimatize for seven d 
before experiment practices. Rats were divided into four groups (n=7 
rats in each): I-control group (CNT); animals were received oral saline 
daily, II-AlCl3 treated group; rats were received daily oral AlCl3 100 
mg/kg body weight, III-ZnO NPs treated group; rats have received ZnO 
NPs 10 mg/kg body weight, orally, once, and in ZnO NPs+AlCl3 treated 
group, rats were administered 10 mg/kg of ZnO NPs one h prior to 100 
mg/kg of AlCl3
Handling of tissues 
. All rats have received their respective doses daily for 6 
w. The present study was approved by the Animal Ethical Committee 
of Helwan University (Cairo, Egypt; approval no. HU2017/Z/09), and 
was conducted by the NIH Guidelines for the Care and Use of 
Laboratory Animals [15, 16]. 
Animals of all groups were sacrificed after 24 h of the last 
administration, and blood was collected in sterilized centrifuged tubes, 
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and then centrifuged at 3000 r pm for 10 min to separate serum for 
biochemical assays. Liver and kidney from rats of all groups were 
quickly dissected and washed with ice-cold phosphate buffer (0.05 M, 
pH 7.4) then subsequently, small pieces from each tissue (100 mg) 
were homogenized in cold phosphate buffer (0.05 M, pH 7.4), and 
centrifuged at 3000 rpm for 10 min at 4  °C. The resulting supernatant 
of all tissue samples from all groups was used for the determination of 
biochemical parameters.  
Measurement of Al and Zn concentration in the liver and kidney of rat  
The concentration of Al and Zn in the liver and kidney tissues was 
assessed using the standardized procedure [17]. In brief, liver and 
kidney tissue samples were weighed and dried in an oven at 100 °C for 
24 h. The dried samples were digested with 2 M nitric acid and 2 M 
hydrochloric acid at 150 °C for 6 h. The samples were diluted with 
deionized H2
Determination of pro-inflammatory markers 
O to a final volume of 50 ml. Aluminum and zinc 
concentrations were assayed by graphite furnace atomic absorption 
spectrophotometry (GFAAS; Perkin-Elmer 3100) at 309.3 and 213.9 
nm, respectively. Al and Zn concentrations were expressed as µg/g of 
wet tissue. All analyses were run in three replicates.  
Biochemical parameters 
Liver and kidney functions assays  
Estimation of Liver and kidney function parameters in blood sera of rats 
from all groups were undertaken. The enzymatic activity of alanine amino-
transaminases (ALT) and aspartate aminotransferase (AST) were 
determined according to the method of [18], bilirubin (Bil) was evaluated 
according to [19], while urea and creatinine were assayed according to [20] 
and [21], respectively, using commercially available diagnostic kits 
(Biodiagnostics-Egypt) as per manufacturer’s instructions. 
Determination of malondialdehyde and nitric oxide levels 
Hepatic and renal level of malondialdehyde (MDA; the end product of 
lipid peroxidation) was determined using thiobarbituric acid according 
to the principle procedure [22]. While the level of nitrite/nitrate (nitric 
oxide, NO) was assayed according to [23]. 
Determination of non-enzymatic and enzymatic antioxidants  
Hepatic and renal tissues homogenates were used to determine 
glutathione (GSH) content according to the method of [24], superoxide 
dismutase (SOD) and catalase (CAT) activities per the procedures 
described [25] and [26], respectively. Whereas, glutathione peroxidase 
(GPx) and glutathione reductase (GR) activities were assayed 
according to the methods described [27] and [28], respectively. 
The levels of pro-inflammatory cytokines namely; tumor necrosis 
factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) in hepatic and 
renal tissues, were determined using enzyme-linked immunosorbent 
assay (ELISA) methods using rat ELISA kits (CUSABIO Life Sciences, 
China) according to the test procedure provided by the manufacturer. 
All samples were run in two replicates.  
Histopathological examination 
Liver and kidney tissue samples from all groups were fixed for 24 h in 10% 
neutral formalin. Following the fixation, tissue samples were passed 
through routine procedures and embedded in paraffin blocks and 
sectioned (4-5 μm). After paraffin was removed, specimens were stained 
consistently with hematoxylin and eosin for microscopic examination 
according to the method described [29]. Images were taken with 400× 
magnification using an Eclipse E200-LED (Nikon, Tokyo, Japan). 
Immunohistochemical analysis 
To investigate nuclear factor-Kappa B (NF-κB) expression in the 
hepato-renal tissue, sections were embedded in paraffin (4-μm 
thickness) and treated with 3% hydrogen peroxide-containing 
methanol for 10 min to block the endogenous peroxidase. Then, 
samples were incubated with the primary antibody at 4 °C overnight. 
Thereafter, all sections were washed with phosphate-buffered saline 
(PBS) and incubated with biotinylated secondary antibody labeled 
with horseradish peroxidase (HRP). The reactions were developed via 
an HRP-catalyzed reaction with diaminobenzidine (DAB), followed by 
counterstaining with hematoxylin. Photographs were taken with 400× 
magnification using an Eclipse E200-LED (Nikon, Tokyo, Japan).  
Statistical analysis 
All data were calculated as the mean±standard deviation (SD). 
Differences between the groups were analyzed using a one-way 
analysis of variance (ANOVA) followed by Tukey’s post hoc test; p 
values<0.05 were being regarded as statistically significant. 
RESULTS 
Accumulation of AlCl3
Daily oral administration of AlCl
 and ZnO NPs in the hepato-renal tissue 
3 at dose 100 mg/kg for 6 w resulted 
in a significant increase in its accumulation at (p<0.05) in the hepatic 
and renal tissues concerning the control group. Meanwhile, in the ZnO 
NPs+AlCl3 group, rats pretreated with ZnO NPs (10 mg/kg) for the 
same period showed a marked decrease in Al accumulation as 
compared with AlCl3
 
-exposed animals as illustrated in fig. 1. 
 
Fig. 1: Accumulation of aluminum and zinc in liver and kidney tissue after daily treatment with zinc oxide nanoparticles (ZnO NPs) and 
aluminum chloride, (AlCl3) for 6 w. Data are expressed as the mean±SD (n = 7). ap<0.05 vs, the Control Group; bp<0.05 vs. the AlCl3-treated 
rats using Tukey post hoc test 
Mahmoud et al. 




Effect of ZnO NPs and/or AlCl3
To analyze the potential protective role of ZnO NPs against AlCl
 treatment on hepato-renal function 
indices  
3-induced 
hepato-renal toxicity, levels of liver and kidney function parameters were 
assessed. ALT, AST, bilirubin, urea, and creatinine levels were found to 
elevate with a significant change at (p<0.05) following AlCl3-intoxication as 
compared to the control group. Whereas, the levels of these physiological 
parameters were modulated significantly in ZnO NPs pretreated rats when 
compared to AlCl3
 
-treated group as represented in table 1. 
Table 1: Effect of zinc oxide nanoparticles (ZnO NPs) and/or aluminum chloride (AlCl3
Experimental 
) after daily treated for 6 w, on liver and kidney function 
parameters alanine aminotransferase (ALT) aspartate aminotransferase (AST), bilirubin (Bil); urea and creatinine in sera of adult male rats 
Groups 
Parameter 
ALT(U/l) AST (U/l) Bil (mg/dl) Urea(mg/dl) Creatinine (mg/dl) 
Control 57.3±8.62 82.7±10.69 0.52±0.07 5.60±1.15 0.92±0.22 
AlCl 143.7±19.603 192.3±16.26a 1.63±0.25a 15.10±2.66a 2.11±0.46a 
 ZnO NPs 
a 
59.3±10.41 87.3±14.57 0.54±0.06 6.00±0.93 0.71±0.16 
ZnO NPs+AlCl 107.3±9.513 154.3±13.51ab 0.83±0.09ab 8.50±0.70ab 1.37±0.20ab ab 
Data are expressed as the mean±SD (n = 7), a: Significant at p ˂ 0.05 with Respect to the Control Group, b: Significant at p ˂ 0.05 with Respect to the AlCl3 
Group 
 
Effect of ZnO NPs and/or AlCl3
To study the oxidative reactions following AlCl
 treatment on oxidant/antioxidant 
parameters  
3-intoxication and the 
potential antioxidant activity of ZnO NPs, the present results determined 
the levels of oxidants and antioxidants in the liver and kidney 
homogenates. As depicted in fig. 2, AlCl3 treatment caused a significant 
(p<0.05) elevation in lipid peroxidation in terms of MDA and also, 
nitrate/nitrite levels while GSH content was depleted as compared with 
the corresponding control values. In contrast, ZnO NPs administration 
suppressed significantly elevated oxidants and increased GSH levels 
when compared against the AlCl3-treated group. Moreover, AlCl3 
exposure inhibited significantly (p<0.05) the cellular antioxidant defense 
enzymes, including SOD, CAT, GPx, and GR, when compared versus the 
control values. However, the activity of these antioxidant enzymes was 
significantly restored toward the control value in ZnO NPs-pretreated 
rats (fig. 3); which reflects its antioxidant capacity against AlCl3
 
-induced 
oxidative damage in the hepato-renal tissue. 
 
Fig. 2: Effect of zinc oxide nanoparticles (ZnO NPs) and/or aluminum chloride (AlCl3) after daily treatment for 6 w, on lipid peroxidation 
(LPO), nitric oxide (NO) and glutathione (GSH) levels in liver and kidney of adult male rats. Data are expressed as the mean ±SD (n= 7). a 
p<0.05 vs. the control group; b p<0.05 vs the AlCl3-treated rats using Tukey post hoc test 
Mahmoud et al. 
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Fig. 3: Effect of zinc oxide nanoparticles (ZnO NPs) and/or aluminum chloride (AlCl3) after daily treatment for 6 w, on antioxidant enzymes 
activity in liver and kidney of adult male rats. Data are expressed as the mean±SD (n = 7). a p<0.05 vs. the control group; b p<0.05 vs. the AlCl3
 
Effect of ZnO NPs and/or AlCl
-
treated rats using Tukey post hoc test.  
3 treatment on inflammatory response 
The present results showed that the accumulation of Al in the liver and 
kidney was found to be associated with the progression of an 
inflammatory response. AlCl3-treated rats exhibited a significant 
increase (at p<0.05) in the production of the pro-inflammatory cytokines 
namely; TNF-α and IL-1β concerning their control rats. Interestingly, the 
levels of these inflammatory cytokines were recovered towards normal 
values in the ZnO NPs and AlCl3 co-administered group (fig. 4). 
Effect of ZnO NPs and/or AlCl3 
As shown in fig. 5, the control group exhibited normal hepatocytes 
architecture showing well-defined central nucleus and abundant 
cytoplasm, while the hepatic tissue of the AlCl




indicated as previously recorded [5] by alterations in hepatic histo-
architecture after 6 w of treatment evidenced by disrupted central vein 
and disarrangement of hepatic cords at most of the places and, also, 
vacuolated hepatocytes, leukocytes infiltration and many Kupffer cells 
and hepatocytes with dense and pyknotic nuclei were observed. ZnO 
NPs administration to animals for 6 w also showed vacuolization and 
disrupted hepatic cords.  
3  treated group indicated revealed that pre-
administration of ZnO NPs preserved, to some extent, the hepatic 
tissue from these pathological alterations caused by AlCl 3 
exposure. 
Mahmoud et al. 
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Liver      Kidney 
  
  
Fig. 4: Effect of zinc oxide nanoparticles (ZnO NPs) and/or aluminum chloride (AlCl3) after daily treatment for 6 w, on interleukin-1β (IL-1β) 
tumor necrosis factor-α (TNF-α) and levels in liver and kidney of adult male rats. Data are expressed as the mean±SD (n = 7). a p<0.05 vs. the 






Fig. 5: Photomicrographs of liver tissue. Where A) represents control, B) aluminum chloride (AlCl3), C) zinc oxide nanoparticles (ZnO NPs) and 
D) aluminum chlorid (AlCl3)+zinc oxide nanoparticles (ZnO NPs) 
Mahmoud et al. 
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Effect of ZnO NPs and/or AlCl3 
As shown in fig. 6, the renal tissue of the control and ZnO NPs-treated 
animals showed an identical kidney structure with normal renal 
tubules and glomeruli. AlCl
treatment on kidney histopathology  
3 intoxication for 42 d resulted in swelling 
of epithelial cells, edema of the inter-tubular spaces, focal hemorrhage, 
inflammatory cell infiltration, vacuolation, and development of 
intraluminal casts as observed previously [5]. Pre-administration of 
ZnO NPs minimized the pathological alterations induced by AlCl3
 
 








Fig. 6: Photomicrographs of kidney tissue. Where A) represents control, B) aluminum chloride AlCl3), C) zinc oxide nanoparticles (ZnO NPs) 
and D) aluminum chloride (AlCl3
 
)+zinc oxide nanoparticles (ZnO NPs) 
 
Mahmoud et al. 
Int J Pharm Pharm Sci, Vol 12, Issue 1, 11-20 
 
17 









Fig. 7: Examination of the expression of nuclear factor Kappa B (NF-kB) in liver I, and kidney tissue II, using immunohistochemical staining 
following the administration of zinc oxide nanoparticles (ZnO NPs) and/or aluminum chloride (AlCl3
 
) for 6 w (magnification 400 ×). A) 
control, B) aluminum chloride, C) zinc oxide nanoparticles and D) aluminum chloride+zinc Oxide nanoparticles 
Effect of ZnO NPs and/or AlCl3 
The immuno-reactivity of NF-κB was estimated in the hepato-renal 
tissue to follow the molecular mechanism of the anti-inflammatory effect 
of ZnO NPs. Rats intoxicated with AlCl
treatment on NF-κB expression  
3 showed overexpression of NF-κB, 
as compared to the control group. On the contrary, expression of NF-κB 
was down-regulated markedly in ZnO NPs and ZnO NPs+AlCl3-treated 
rats, when compared against AlCl3
DISCUSSION  
-treated rats. These findings indicate 
the anti-inflammatory activity of ZnO NPs used dose (fig. 7). 
The liver plays a major role in the detoxification process; hepatocytes 
were considered as a massive detoxification center protecting the body 
from the deleterious effects [30]. Studies indicated that nanoparticles 
have superior physicochemical, mechanical, thermal and biological 
properties and also, better catalytic activities as compared to bulk 
materials, therefore zinc nanoparticles were reported to have various 
biological and pharmacological activities; such as antimicrobial, 
antioxidant, anti-inflammatory, anti-tumor, hepato-renal protective 
and immunomodulatory activity [11, 12, 31-36].  
Data availability concerning the accumulation of ZnO NPs in rat liver and 
kidney following AlCl3 intoxication was limited. The present results 
indicated that ZnO NPs decreased Al accumulation in hepato-renal tissue, 
while increased Zn content in both tissues when assayed in ZnO 
NPs+AlCl3
The hepato-renal tissues were considered as target organs for ZnO NPs 
accumulation and toxicity in rats [39]. The observed increase in Zn 
concentration in the hepato-renal tissue, in the present study, could be 
attributed to their preferential passage through the lymphatic system, 
-treated rats group. The accumulation of NPs in the liver and 
kidney of mice after intravenous administration was documented [37]. 
Likely, an increase in the nano-zinc level in different tissues of mice was 
also reported [38]. Authors showed that ZnO NPs may be absorbed into 
circulation within 30 min, after i. p. injection, and remained in serum for 
72 h and ZnO NPs were bio-distributed into the liver, spleen, and kidney 
thereby, spreading to the heart, lung, and testes [38].  
Mahmoud et al. 
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owing to permeability differences [40] and their high surface 
reactivity, small size, and shape, which easily cross cell membranes to 
interact with biomolecules leading to disruption of trace elements 
homeostasis [41, 42]. Also, to the first-pass effects, as a previous study 
[43] showed fast dissolution of zinc NPs in the stomach was found to 
increase zinc level, in the systemic circulation of CdCl2
Liver enzymes and kidney functions (ALT, AST, Bil, urea, and 
creatinine) in serum were considered as important serum parameters 
for investigating animal health [46]. Biochemical analysis of liver and 
kidney function parameters of AlCl
-hepatorenal 
injured mice treated with ZnO NPs and followed by zinc ions 
redistribution from the liver to other organs. Another reason for Zn 
accumulation was the induction of tissues metallothionein (cytosolic 
cysteine-rich proteins, powerful scavenger of free radicals) [44] for 
controlling metal homeostasis to maintain cell survival in response to 
various stimuli [39], and also to the role of Zn in the synthesis, storage, 
and secretion of insulin [45].  
3-treated rats indicated their 
marked elevation, and these results were supported by 
histopathological examination of the hepato-renal tissue of rats treated 
with AlCl3, which indicated altered hepatic histo-architecture after 6 w 
of treatment appearing as vacuolated hepatocytes and leukocytes 
infiltration. Examined kidney sections showed swelling of epithelial 
cells, edema of the inter-tubular spaces, focal hemorrhage, 
inflammatory cell infiltration, and vacuolization. Observations of the 
present study were following previous studies [47, 5]. These changes 
were attributed to the altered hepatic cell membrane permeability, 
increased MDA and NO levels, as reported also in the present study, as 
AlCl3 intoxication produces an excess of oxygen-free radicals and 
alters physiological function which plays an important role in cellular 
membrane damage through free radical chain reaction mechanism [47, 
5]. Data from ZnO NPs+AlCl3-treated rats group, concerning liver and 
kidney functions (AST, ALT, Bil, urea, and creatinine) and evaluation of 
the antioxidant enzymes activity in rat hepatic and renal tissues, 
indicated the potential ameliorative effect of ZnO NPs administration 
(10 mg/kg body weight) with their particular size, on the hepato-renal 
tissues of AlCl3
The decreased GSH content and antioxidant enzyme activities (SOD, 
CAT, GPx and GR) found in the hepato-renal tissues of AlCl
-intoxicated rats, reflecting their role in protecting the 
hepato-renal tissue function against Al-intoxication. 
3
The histopathological changes in the hepato-renal tissue of the ZnO 
NPs+AlCl
-treated 
rats agreed with previous studies [48, 5]. Meanwhile, the antioxidant 
enzymes activities of SOD, CAT, GR, and GPx in liver of ZnO NPs-treated 
rats group showed their tendency to elevate, suggesting that 
administration of ZnO NPs alone may potentiate the antioxidant status 
in rats either in the liver or kidney of ZnO NPs-treated group as ZnO 
NPs may induce highly reactive oxygen species, which cause oxidative 
damage to animal cells [49]. Histopathological examination of ZnO 
NPs-treated rats supported the biochemical analysis, indicating 
disruption of hepatic cords and vacuolization. Moreover, ZnO NPs toxic 
effect of on liver enzymes was reported [50], as ALT and AST are 
located primarily in the cytosol of hepatocytes [49]. These results 
reveal that ZnO NPs may interrupt the functions of liver cells, due to 
excess zinc inside cells leading to apoptosis [51] taking into 
consideration using ZnO NPs with different morphological properties. 
Zinc also was reported to maintain the activity of tumor suppressor 
gene p53 thus regulating apoptosis activity, and helping inactivation of 
the caspase-6 enzyme responsible for apoptosis [52].  
3-treated rats group, in the present work, were found to 
decrease and this could be attributed to decreased lipid peroxidation, 
enhanced antioxidant enzymes (CAT and SOD) and preserved GSH 
content in both tissues. As zinc was reported to play a vital role in 
cellular GSH regulation and cellular antioxidant defense [53], 
controlling free radicals and oxidative stress for SOD activity which 
was documented to have Zn2+ and Cu2+ in its active site thus playing a 
crucial role in the defense against oxidative stress. The increased SOD 
activity in the hepato-renal tissue of ZnO NPs+AlCl3
Both SOD and CAT were considered as a defense against oxidative cell 
injury, as CAT decomposes hydrogen peroxide to water and oxygen. 
CAT and SOD activities in hepatic and renal tissues were mostly 
recovered in the co-administered group, while GPx and GR activities 
were partially ameliorated in both tissues. They were documented for 
their role in sulfhydryl group’s protection against oxidation [57], 
preservation of intracellular levels of reduced GSH and the reduced 
production of LPO products [58]. GSH is considered as a substrate for 
GST and GPx activities, therefore its shortage might cause a diminution 
in their activities. GST constituted a family of phase II detoxification 
enzymes specialized for detoxification of xenobiotics and in the 
signaling cascades [59], while, GPx was involved in converting H
 of the present 
work enhanced the break-down of superoxide into oxygen and 
hydrogen peroxide thus conserving the superoxide radicals 
concentration at low levels and this could be attributed to the 
availability of ZnO NPs [54, 55, 43], thereby increasing the mRNA 
expression of SOD, CAT, GPx, and GR leading to enhanced activity thus 
ameliorating oxidative stress [56]. 
2O2 
and organic hydro-peroxides to less reactive products [60]. A decrease 
in the GST activity might result in xenobiotic accretion; whereas the 
decrease in the GPx activity might accompany H2O2
After induction of oxidative stress, many released pro-inflammatory 
cytokines and chemokines through the inflammatory process were 
considered as a key event in hepatic stellate cells activation [62, 63], as 
ROS play a critical role in the activation of cells as messengers in the 
signal transduction pathways leading to gene expression [64]. Zinc 
supplementation was reported to inhibit hepatic stellate cells activation 
after ethanol and acetaldehyde administration, therefore acting as an 
antioxidant and inhibiting several markers of hepatic stellate cells 
activation [65]. Besides the role of Zinc in decreasing hepatic lipid 
peroxidation [66], zinc was documented to reduce transforming growth 
factor-β and to induce epithelial differentiation and fibroblast activation 
thus protecting the liver against fibrosis [67]. Zinc is a potent inducer of 
metallothioneins, plays a key role in cellular defense against metal 
toxicity [68], and involved in phagocytosis, antigen presentation by 
macrophages, and inflammatory responses [32]. 
 accumulation 
leading to further inactivation in its activity. SOD, CAT, and GPx 
constitute a supportive team of enzymes providing defense against 
ROS [61]. 
Results of the present study, indicated that ZnO NPs treatment to AlCl3
The observed ameliorative effect of ZnO NPs on the histopathological 
changes of the hepato-renal tissue, in ZnO NPs+Al treated rats group 
could be attributed to decreased lipid peroxidation, enhanced 
antioxidant enzymes activities (CAT and SOD) and preserved GSH 
content in hepato-renal tissue. Zinc was found to ameliorate oxidative 
stress and glutathione depletion and involved in all processes concerned 
with cell protection through activation of DNA repair, thus preventing 
apoptosis and cell proliferation [71]. ZnO NPs act as an effective adjuvant 
treatment to chemotherapeutic drugs that may cause male reproductive 
dysfunction [31] and as a hepatic cytoprotective agent against Aflatoxin 
B1 exposure, when used in low doses, by improving the antioxidant 
activity, and decreasing the free radicals level [72]. Studies also showed 
suppressed MDA content by ZnO NPs treatment in a dose-dependent 
manner, thus reducing oxidative stress [69, 35], therefore, protecting cell 
membrane integrity against oxidative stress damage, and increasing 
antioxidant enzyme levels [73]. 
 
treated rats decreased IL-1β and TNF-α levels which could be 
attributed to the anti-inflammatory activity of ZnO NPs that suppress 
mRNA expression of both cytokines and also to the suppression of 
inducible nitric synthase, cyclooxygenase-2 and interleukin-6 levels 
[12]. Moreover, reports revealed decreased levels and activity of 
myeloperoxidase (found in neutrophils; catalyzes the formation of 
ROS) which affect cytokines production [69, 35]. Furthermore, ZnO 
NPs were found to enhance T cells functionality, having an adjuvant 
effect toward T helper-2 response, thus increasing production and 
activation of cytokines [32]. Furthermore, ZnO NPs were found to act 
as an immuno-modulator by increasing antigen-specific immune 
reactions in mice, and enhancing antigen-specific antibodies 
production in serum, especially; immunoglobulin E and G [32, 70]. 
The immunohistochemical analysis of the hepato-renal tissue from the 
Al-treated group indicated overexpression of NF-kB, while sections from 
the ZnO NPs+AlCl3-treated rats group showed decreased expression, 
evidenced in the present study by decreased NO, Il-β and TNF-α levels of 
the same group. Balanced cell survival and cell death were reported to be 
created through Zinc channels via controlling free and intracellular zinc 
movements [74]. Due to their unique properties, ZnO NPs being 
bioavailable, biocompatible with high solubility and may localize in many 
Mahmoud et al. 
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tissues for cellular cycle regulation and cellular homeostasis 
maintenance, as they were supposed to mimic biomolecules' activity 
[75]. Moreover, ZnO NPs exposure suppressed NF-κB activity and 
translocation of nuclear ion of NF-kB and p65 in LPS-induced RAW 
macrophages, together with decreased transcription of cellular proteins 
leading to inhibition of NF-κB, thereby suppressing IL-1β and TNF-α 
production [76]. Furthermore, ZnO NPs may exert an immune-regulatory 
role by blocking the caspase-1 enzyme in activated mast cells leading to 
the release of different inflammatory mediators and NF-κB as well [36]. 
CONCLUSION 
Zinc Oxide nanoparticles ameliorated AlCl3
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ethical principles outlined in the Declaration of Helsinki. 
FUNDING  
This research received no specific grant from any funding agency in the 
public, commercial or not-for-profit sectors.  
AUTHORS CONTRIBUTIONS  
All 3 authors participated in the practical work and writing of the 
manuscript. All authors have complete access to the study data that 
support the publication. 
CONFLICT OF INTERESTS  
The authors declare that they have no conflict of interest  
REFERENCES  
1. Verstraeten S, Aimo L, Oteiza PI. Aluminium and lead: molecular 
mechanisms of brain toxicity. Arch Toxicol 2008;82:789-802. 
2. Bhadauria M. Combined treatment of HEDTA and propolis 
prevents aluminum-induced toxicity in rats. Food and chemical 
toxicology. Br Ind Biol Res Assoc 2012;50:2487-95. 
3. Willhite CC, Karyakina NA, Yokel RA, Yenugadhati N, Wisniewski 
TM, Arnold IM, et al. Systematic review of potential health risks 
posed by pharmaceutical, occupational and consumer exposures 
to metallic and nanoscale aluminum, aluminum oxides, aluminum 
hydroxide and its soluble salts. Crit Rev Toxicol 2014;(44 Suppl 
4):1-80. 
4. Turkey H, Yousef MI, Biyikoglu F. Propolis prevents aluminum-
induced genetic and hepatic damages in rat liver. Food Chem 
Toxicol 2010;48:2741-6. 
5. Abdel Moneim AE, Othman MS, Mahmoud SM, El-Deib KM. 
Pomegranate peel attenuates aluminum-induced hepatorenal 
toxicity. Toxicol Mech Methods 2013;23:624-33. 
6. El-Kenawy AM, Osman HEH, Daghestani MH. Role of propolis (bee 
glue) in improving histopathological changes of the kidney of rat 
treated with aluminum chloride. Environ Toxicol 2014;29:1000-
10. 
7. Mahitha B, Raju BDP, Mallikarjuna K, Durga Mahalakshmi C, 
Sushmal N, Bacopa monniera NJ. Stabilized silver nanoparticles 
attenuates oxidative stress induced by aluminum in albino mice. J 
Nanosci Nanotech 2015;15:1101-9. 
8. Narayanan KB, Park HH. Pleiotropic functions of antioxidant 
nanoparticles for longevity and medicine. Adv Coll Sci 2013;201-
202:30-42.  
9. Abhinaya SR, Padmini R. Biofabrication of zinc oxide 
nanoparticles using pterocarpus marsupium and its biomedical 
applications. Asian J Pharm Clin Res 2019;12:245-9. 
10. Jacob V, Rajiiv P. In vitro analysis: the antimicrobial and 
antioxidant activity of zinc oxide nanoparticles from Curcuma 
longa. Asian J Pharm Clin Res 2019;12:200-4. 
11. Manyasree D, Kiranmyi P, Kolli VR. Characterization and 
antibacterial activity of ZnO nanoparticles synthesized by the co-
precipitation method. Int J Appl Pharm 2018;10:224-8. 
12. Nagajyothi PC, Cha SJ, Yang IJ, Sreekanth TV, Kim KJ, Shin HM. 
Antioxidant and anti-inflammatory activities of zinc oxide 
nanoparticles synthesized using Polygala tenuifolia root extract. J 
Photochem Photobiol Biol 2015;146:10-7. 
13. Najafzadeh H, Ghoreishi SM, Mohammadian B, Rahimi E, 
Afzalzadeh MR, Kazemi Varnamkhasti M, et al. Serum biochemical 
and histopathological changes in liver and kidney in lambs after 
zinc oxide nanoparticles administration. Vet World 2013;6:534-7. 
14. Abdel Moneim AE. Indigofera oblongifolia prevents lead acetate-
induced hepatotoxicity, oxidative stress, fibrosis and apoptosis in 
rats. PLoS One 2016;11:1-18. 
15. NIH (National Institute Of Health). Memorandum of 
Understanding Among the Animal and Plant Health Inspection 
Service USDA and the Food and Drug Administration, US 
Department of Health and Human Services and the National 
Institutes of Health Concerning Laboratory Animal Welfare. Office 
of Extramural Research: NIH, Bethesda; 2006.  
16. NIH (National Institutes of Health). Memorandum of 
Understanding Between the Office of Laboratory Animal Welfare, 
National Institutes of Health, US Department of Health and 
Human Services and the Office of Research Oversight and the 
Office of Research and Development, Veterans Health 
Administration, US Department of Veterans Affairs Concerning 
Laboratory Animal Welfare. Office of Extramural Research: NIH, 
Bethesda; 2007.  
17. Kubaszewski L, Ziola Frankowska A, Frankowski M, Nowakowski 
A, Czabak-Garbacz R, Kaczmarczyk J, et al. Atomic absorption 
spectrometry analysis of trace elements in degenerated 
intervertebral disc tissue. Med Sci Mon 2014;20:2157-64.  
18. Reitman S, Frankel SA. Colorimetric method for the determination 
of serum glutamic oxaloacetic and glutamic pyruvic 
transaminases. Am J Clin Path 1957;28:56-63.  
19. Walter M, Gerade H. Bilirubin assay. Microchem J 1970;15:231-6.  
20. Fawcett JK, Scott JE. A rapid and precise method for the 
determination of Urea. J Clin Path 1960;13:156-9. 
21. Schirmeister J, Willmann H, Kiefer H. Determination of creatinine 
in serum. D Med Wochen 1964;89:1940 
22. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues 
by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8. 
23. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, 
Tannenbaum SR. Analysis of nitrate, nitrite, and [15
24. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 
1959;82:70-7. 
N]nitrate in 
biological fluids. Anal Biochem 1982;126:131-8.  
25. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of 
superoxide dismutase. Clin Chem 1988;34:497-500. 
26. Luck H. Catalase. In: HU Bergmeyer. Ed. Methods of enzymatic 
analysis. Academic Press: New York; 1965. p. 855-88. 
27. Paglia DE, Valentine WN. Studies on the quantitative and 
qualitative characterization of erythrocyte glutathione 
peroxidase. J Lab Clin Med 1967;70:158-69.  
28. Factor VM, Kiss A, Woitach JT, Wirth PJ, Thorgeirsson SS. 
Disruption of redox homeostasis in the transforming growth 
factor-alpha/c-myc transgenic mouse model of accelerated 
hepatocarcinogenesis. J Biol Chem 1998;273:15846-53. 
29. Bancroft J, Gamble M. Bancroft's theory and practice of 
histological techniques. Eds. Vol. 6th Edition. Elsevier, London: 
Churchill Livingstone; 2008. 
30. Mescher MJA. Basic histology: text and atlas. 13th Ed. McGraw-
Hill Education; 2013. p. 329-39. 
31. Badkoobeh P, Parivar K, Kalantar SM, Hosseini SD, Salabat A. 
Effect of nano-zinc oxide on doxorubicin-induced oxidative stress 
and sperm disorders in adult male wistar rats. Iran J Reprod Med 
2013;11:355-64.  
32. Roy R, Kumar S, Verma AK, Sharma A, Chaudhari BP, Tripathi A, et al. 
Zinc oxide nanoparticles provide an adjuvant effect to ovalbumin via a 
Th2 response in Balb/c mice. Int Immun 2014;26:159-72. 
33. Bisht G, Rayamajhi S. ZnO nanoparticles: a promising anticancer 
agent. Nanobiomed 2016;3:9.  
Mahmoud et al. 
Int J Pharm Pharm Sci, Vol 12, Issue 1, 11-20 
 
20 
34. Yuan Y, Cai T, Xia X, Zhang RP, Cai CY. Nanoparticle delivery of 
anticancer drugs overcomes multidrug resistance in breast 
cancer, Drug Delivery 2016;23:3350–7. 
35. Li J, Chen H, Wang B, Cai C, Yang X, Chai Z, et al. ZnO nanoparticles 
act as supportive therapy in DSS-induced ulcerative colitis in mice 
by maintaining gut homeostasis and activating Nrf2 signaling. Sci 
Rep 2017;7:43126. 
36. Agarwal H, Nakara A, Shanmugam VK. Anti-inflammatory 
mechanism of various metal and metal oxide nanoparticles 
synthesized using plant extracts. Rev Biomed Pharmacoth 
2019;109:2561–72. 
37. Chen JK, Shih MH, Peir JJ. The use of radioactive zinc oxide 
nanoparticles in the determination of their tissue concentrations 
following intravenous administration in mice. Analyst 
2010;135:1742–6. 
38. Li CH, Shen CC, Cheng YW, Huang SH, Wu CC, Kao CC, et al. Organ 
biodistribution, clearance, and genotoxicity of orally 
administered zinc oxide nanoparticles in mice. Nano Toxicol 
2012;6:746–56. 
39. Amara S, Ben Slama I, Mrad I, Rihane N, Khemissi W, El Mir L, et 
al. Effects of zinc oxide nanoparticles and/or zinc chloride on 
biochemical parameters and mineral levels in rat liver and 
kidney. Hum Exp Toxicol 2014;33:1150-7. 
40. Liu J, Wong HL, Moselhy J, Bowen B, Wu XY, Johnston MR. 
Targeting colloidal particulates to thoracic lymph nodes. Lung 
Can 2006;51:377–86. 
41. Xiong D, Fang T, Yu L, Sima X, Zhu W. Effects of nano-scale TiO2, ZnO 
and their bulk counterparts on zebrafish: acute toxicity, oxidative 
stress, and oxidative damage. Sci Environ 2011;409:1444-52. 
42. Lee CM, Jeong HJ, Yun KN, Kim DW, Sohn MH, Lee JK. Optical 
imaging to trace near-infrared fluorescent zinc oxide nanoparticles 
following oral exposure. Int J Nanomed 2012;7:3203–9. 
43. Gao S, Wang X, Wang S, Zhu S, Rong R, Xu X. Complex effect of zinc 
oxide nanoparticles on cadmium chloride-induced hepatotoxicity 
in mice: protective role of metallothionein. Metall 2017;1:706-14.  
44. Suntres ZE, Lui EM. Biochemical mechanism of metallothionein-
carbon tetrachloride interaction in vitro. Biochem Pharmacol 
1990;39:833-40.  
45. Yaghmaei P, Esfahani Nejad H, Ahmadi R, Hayati Roodbari N, 
Ebrahim Habibi A. Maternal zinc intake of wistar rats has a 
protective effect in the alloxan-induced diabetic offspring. J 
Physiol Biochem 2013;69:35–43. 
46. Canli EG, Canli M. Effects of aluminum, copper, and titanium 
nanoparticles on some blood parameters in wistar rats. Turk J 
Zool 2017;41:259-66.  
47. Wong Ekkabut J, Xu Z, Triampo W, Tang IM, Tieleman DP, Monticelli L. 
Effect of lipid peroxidation on the properties of lipid bilayers: a 
molecular dynamics study. Biophys J 2007;93:4225-36.  
48. Shati AA, Alamri SA. Role of saffron (Crocus sativus L.) and honey 
syrup on aluminum-induced hepatotoxicity. Sau Med J 
2010;31:1106-13. 
49. Sharma V, Singh P, Pandey AK, Dhawan A. Induction of oxidative 
stress, DNA damage and apoptosis in mouse liver after sub-acute 
oral exposure to zinc oxide nanoparticles. Mut Res Genet Toxicol 
Env Mut 2012;745:84-91. 
50. Fazilati M. Investigation toxicity properties of zinc oxide 
nanoparticles on liver enzymes in the male rat. Eur J Exp Biol 
2013;3:97-103. 
51. John E, Laskow TC, Buchser WJ, Pitt BR, Basse PH. Zinc in innate 
and adaptive tumor immunity. J Transl Med 2010;8:118˗20. 
52. Ng KW, Khoo SP, Heng BC. The role of the tumor suppressor p53 
pathway in the cellular DNA damage response to zinc oxide 
nanoparticles. Biomat 2011;32:8218-25.  
53. Parat MO, Richard M, Beani, JC, Favier A. Involvement of zinc in 
Intracellular oxidant/antioxidant balance. Biol Trace Elem Res 
1997;60:187-204.  
54. Fridovich I. Superoxide anion radical (O· 2), superoxide 
dismutases, and related matters. J Biol Chem 1997;272:18515-7.  
55. Peixoto EB, Pessoa BS, Biswas SK, Lopes de Faria JB. Antioxidant 
SOD mimetic prevents NADPH oxidase-induced oxidative stress 
and renal damage in the early stage of experimental diabetes and 
hypertension. Am J Neph 2009;29:309–18.  
56. Afifi M, Abdelazim AM. Ameliorative effect of zinc oxide and silver 
nanoparticles on the antioxidant system in the brain of diabetic 
rats. Asian Pac J Trop Biomed 2015;5:874–7. 
57. Bray TM, Bettger WJ. The physiological role of zinc as an 
antioxidant. Free Rad Biol Med 1990;8:281-91.  
58. Bao B, Ahmad A, Azmi A, Li Y, Prasad A, Sarkar FH. The biological 
significance of zinc in inflammation and aging. In: Inflammation, 
Advancing age and Nutrition: Research and Clinical Interventions. 
1st ed. Edited by Rahman I, Bagchi D. New York, NY, Elsevier Inc, 
Chapter 2; 2013. p. 15–27. 
59. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases the 
first enzymatic step in mercapturic acid formation. J Biol Chem 
1974;249:7130–9. 
60. Halliwell B, Gutteridge JMC. Free radicals in biology and. Oxford 
University Press: New York; 1999. 
61. Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, 
et al. Glutathione peroxidase, superoxide dismutase, and catalase 
inactivation by peroxides and oxygen-derived free radicals. Mech 
Age Development 1990;15:283–97.  
62. Greenwel P, Dominguez Rosales JA, Mavi G, Rivas Estilla AM, 
Rojkind M. Hydrogen peroxide: a link between acetaldehyde-α1 
(i) collagen gene up-regulation and oxidative stress in mouse 
hepatic stellate cells. Hepatol 2000;31:109-16.  
63. Pinzani M, Macias Barragan J. Update on the pathophysiology of 
liver fibrosis. Exp Rev Gastroent Hep 2010;4:459-72.  
64. Dagher Z, Garcon G, Billet S. Role of nuclear factor-kappa B 
activation in the adverse effects induced by air pollution 
particulate matter (PM2.5) in human epithelial lung cells (L132) 
in culture. J Appl Toxicol 2007;27:284–90. 
65. Szuster Ciesielska A, Plewka K, Daniluk J, Kandefer Szerszen M. 
Zinc supplementation attenuates ethanol-and acetaldehyde-
induced liver stellate cell activation by inhibiting reactive oxygen 
species (ROS) production and by influencing intracellular 
signaling. Biochem Pharmacol 2009;78:301-14.  
66. Situnayake RD, Crump BJ, Thurnham DI, Davies JA, Gearty J, Davis 
M. Lipid peroxidation and hepatic antioxidants in alcoholic liver 
disease. Gut 1990;31:1311-7.  
67. Sorensen Zender I, Bhayana S, Susnik N, Rolli V, Batkai S, Arpita B, 
et al. Zinc-α2-glycoprotein exerts antifibrotic effects in kidney 
and heart. J Am Soc Neph 2015;26:2659–68.  
68. Moos PJ, Olszewski K, Honeggar M. Responses of human cells to ZnO 
nanoparticles: a gene transcription study. Metall 2011;3:1199–211. 
69. Kim MH, Seo JH, Kim HM, Jeong HJ. Aluminum-doped zinc oxide 
nanoparticles attenuate the TSLP levels via suppressing caspase-
1 in activated mast cells. J Biom Appl 2016;30:1407–16. 
70. Pei X, Xiao Z, Liu L, Wang G. Effects of dietary zinc oxide 
nanoparticles supplementation on growth performance, zinc 
status, intestinal morphology, microflora population, and immune 
response in weaned pigs. J Sci Food Agric 2019;99:1366-74.  
71. Ho E. Zinc deficiency, DNA damage and cancer risk. J Nutr 
Biochem 2004;15:572-8.  
72. Atef HA, Mansour MK, Ibrahim EM. Efficacy of zinc oxide 
nanoparticles and curcumin in amelioration the toxic effects in 
aflatoxicated rabbits. Int J Curr Microl Appl 2016;5:795-818.  
73. Dawei AI, Zhisheng W, Anguo Z. Protective effects of Nano-ZnO on 
the primary culture mice intestinal epithelial cells in in vitro 
against oxidative injury. J Anim Vet Adv 2009;8:1964-7. 
74. Dhawan DK, Chadha VD. Zinc: a promising agent in dietary 
chemoprevention of cancer. India J Med Res 2010;132:676-82. 
75. Elshama SS, Abdallah ME, Abdel Karim RI. Zinc oxide 
nanoparticles: therapeutic benefits and toxicological hazards. 
Open Nanomed J 2018;5:16-22. 
76. Kim MH, Jeong HJ. Zinc oxide nanoparticles suppress LPS-Induced 
NF-κ B activation by inducing A20, a negative regulator of NF-κ B, in 
RAW 264.7 macrophages. J Nanosci Nanotech 2015;15:6509–15.
 
